The U.S. Department of Health and Human Services Food and Drug Administration (FDA) has awarded a $843,312.92 cost-reimbursement Indefinite Delivery Contract to the Hawaii Department of Health Alcohol and Drug Abuse Division (ADAD), a state government entity. This contract, running from 2024 to 2029, supports the FDA's tobacco retail compliance programs aimed at reducing underage access to tobacco products. Under this contract, ADAD will conduct undercover inspections of tobacco retailers throughout Hawaii.
In addition to this contract, ADAD receives significant federal grant funding from agencies such as the Substance Abuse and Mental Health Services Administration (SAMHSA) and Centers for Disease Control and Prevention (CDC) to implement substance abuse prevention, treatment, and recovery initiatives in Hawaii. These grants include the $20+ million annual Substance Abuse Prevention and Treatment Block Grant, the $36 million Hawaii State Opioid Response grant, the $5.5 million Overdose Data to Action cooperative agreement, and the $3.75 million Strategic Prevention Framework Partnerships for Success grant.
Generated 12/31/24, 2:02 PM